The Latest Science on Ketamine: A Breakthrough for Mental Health & Pain
Mental Health

The Latest Science on Ketamine: A Breakthrough for Mental Health & Pain

Rocky Jedick MD
May 16, 2026
6 min read
Back to Blog

Once known primarily as an anesthetic, ketamine has emerged as one of the most significant medical breakthroughs in modern psychiatry and pain management. While only the esketamine nasal spray is formally FDA-approved (for Treatment-Resistant Depression), the intravenous (IV) administration of racemic ketamine is widely utilized off-label due to its profound, rapid, and life-changing effects. But what does the latest science actually say? Here is a breakdown of the most recent evidence-based research as of 2025.

How Ketamine Works Differently

Traditional antidepressants like SSRIs target the monoamine system (serotonin, dopamine, norepinephrine) and can take 4 to 6 weeks to take effect—if they work at all. Ketamine takes a completely different path. It acts primarily as an NMDA receptor antagonist, modulating the brain's glutamate system. Glutamate is the most abundant excitatory neurotransmitter in the brain. By modulating it, ketamine triggers a surge of neural plasticity—essentially helping the brain grow new neural connections and repair neurocircuitry damaged by chronic stress, trauma, and depression. This is why ketamine can provide relief within hours or days, rather than weeks.

Beyond the brain, ketamine also targets the opioid system and plays a role in anti-inflammatory processes, which explains its dual efficacy in both mental health and chronic pain.

1. Treatment-Resistant Depression (TRD) & Suicidality

The strongest body of evidence for ketamine lies in treating TRD. A major 2025 study from Mass General Brigham compared IV ketamine against intranasal esketamine. The findings were clear: both are highly effective, but IV ketamine showed an earlier and greater improvement in depression severity. Patients often exhibited improved symptoms immediately after their very first IV treatment.

Furthermore, ketamine is unparalleled in acute crisis intervention. For individuals experiencing severe suicidal ideation, ketamine's rapid-acting properties can reduce suicidal thoughts within hours, providing a crucial bridge to safety when traditional therapies are too slow.

2. Post-Traumatic Stress Disorder (PTSD)

Evidence for ketamine's use in PTSD is growing rapidly. A massive 2025 real-world study analyzing over 8,000 PTSD patients found that Ketamine Intravenous Therapy (KIT) significantly reduced both PTSD and comorbid depression symptoms. The research indicated that the most dramatic symptom reductions occur within the first three treatments. The therapy helps patients process trauma without the overwhelming emotional activation that typically accompanies it, though experts note that for chronic PTSD, ketamine is most effective when paired with ongoing psychotherapy (Ketamine-Assisted Psychotherapy or KAP).

3. Chronic Pain Conditions

Ketamine is showing immense promise for severe, treatment-resistant chronic pain, including neuropathic pain, fibromyalgia, and Complex Regional Pain Syndrome (CRPS). A major 2025 study from the Cleveland Clinic analyzed over 1,000 chronic pain patients who underwent a specialized 5-day low-dose ketamine infusion protocol. The results demonstrated sustained improvements at both 3 and 6 months follow-ups—not just in pain reduction, but in physical functioning, social role satisfaction, and reduced pain catastrophizing.

Safety and the Importance of the Medical Setting

While the benefits are profound, ketamine is a powerful medication that requires respect. High-dose, frequent, or recreational use carries serious risks, including cognitive impairment, addiction, and severe bladder damage (cystitis). This is why evidence-based practice guidelines strictly recommend that ketamine only be administered in a specialized, controlled medical clinic.

In a clinical setting like Peak Hydration Spa, sub-anesthetic doses are carefully calculated based on weight (e.g., 0.5 mg/kg for pain or 0.6-0.8 mg/kg for mental health) and administered over a specific time frame while the patient's vitals (blood pressure, heart rate) and dissociative state are continuously monitored by medical professionals.

Looking Forward

Ketamine is shifting the paradigm from managing symptoms to actually repairing neural pathways. As a physician-led clinic, we are committed to following the latest evidence-based protocols to provide safe, effective, and transformative care for our patients suffering from chronic pain and mental health conditions.

Scientific References & Further Reading

Disclaimer: IV Ketamine for mood and pain disorders is an off-label use. This article is for informational purposes and does not constitute medical advice. A comprehensive medical evaluation is required to determine if ketamine therapy is appropriate for you.

Share this article: